336 related articles for article (PubMed ID: 29441062)
1. TGF-β-Induced CD8
Zhong H; Liu Y; Xu Z; Liang P; Yang H; Zhang X; Zhao J; Chen J; Fu S; Tang Y; Lv J; Wang J; Olsen N; Xu A; Zheng SG
Front Immunol; 2018; 9():35. PubMed ID: 29441062
[TBL] [Abstract][Full Text] [Related]
2. CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39.
Zhang X; Ouyang X; Xu Z; Chen J; Huang Q; Liu Y; Xu T; Wang J; Olsen N; Xu A; Zheng SG
Mol Ther; 2019 Nov; 27(11):1963-1973. PubMed ID: 31402273
[TBL] [Abstract][Full Text] [Related]
3. CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.
Deng W; Xu M; Meng Q; Li Z; Qiu X; Yin S; Sun D; Dai C; Liu Y
Rheumatology (Oxford); 2019 Nov; 58(11):2039-2050. PubMed ID: 31329981
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells.
Liu Y; Lan Q; Lu L; Chen M; Xia Z; Ma J; Wang J; Fan H; Shen Y; Ryffel B; Brand D; Quismorio F; Liu Z; Horwitz DA; Xu A; Zheng SG
J Mol Cell Biol; 2014 Feb; 6(1):81-92. PubMed ID: 23861553
[TBL] [Abstract][Full Text] [Related]
5. In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease.
Zhao D; Zhang C; Yi T; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
Blood; 2008 Sep; 112(5):2129-38. PubMed ID: 18550852
[TBL] [Abstract][Full Text] [Related]
6. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome.
Zheng SG; Wang JH; Koss MN; Quismorio F; Gray JD; Horwitz DA
J Immunol; 2004 Feb; 172(3):1531-9. PubMed ID: 14734731
[TBL] [Abstract][Full Text] [Related]
7. Efficient Therapeutic Function and Mechanisms of Human Polyclonal CD8
Sun J; Yang Y; Huo X; Zhu B; Li Z; Jiang X; Xie R; Gao L; Sun Y; Fan H; Zhu Y; Yang J
J Immunol Res; 2019; 2019():8575407. PubMed ID: 30915372
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism.
Xu A; Liu Y; Chen W; Wang J; Xue Y; Huang F; Rong L; Lin J; Liu D; Yan M; Li QZ; Li B; Song J; Olsen N; Zheng SG
J Immunol; 2016 May; 196(9):3631-41. PubMed ID: 27001954
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CD103 expression by CD8+ T cells responding to renal allografts.
Wang D; Yuan R; Feng Y; El-Asady R; Farber DL; Gress RE; Lucas PJ; Hadley GA
J Immunol; 2004 Jan; 172(1):214-21. PubMed ID: 14688328
[TBL] [Abstract][Full Text] [Related]
10. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
Gunnlaugsdottir B; Maggadottir SM; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
[TBL] [Abstract][Full Text] [Related]
11. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
[TBL] [Abstract][Full Text] [Related]
12. Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.
Foster AD; Haas M; Puliaeva I; Soloviova K; Puliaev R; Via CS
Clin Immunol; 2010 Jul; 136(1):61-73. PubMed ID: 20451460
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.
Zhang L; Bertucci AM; Ramsey-Goldman R; Burt RK; Datta SK
J Immunol; 2009 Nov; 183(10):6346-58. PubMed ID: 19841178
[TBL] [Abstract][Full Text] [Related]
14. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets.
Kang HK; Michaels MA; Berner BR; Datta SK
J Immunol; 2005 Mar; 174(6):3247-55. PubMed ID: 15749855
[TBL] [Abstract][Full Text] [Related]
15. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
El-Asady R; Yuan R; Liu K; Wang D; Gress RE; Lucas PJ; Drachenberg CB; Hadley GA
J Exp Med; 2005 May; 201(10):1647-57. PubMed ID: 15897278
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease.
Heiler S; Lötscher J; Kreuzaler M; Rolink J; Rolink A
Front Immunol; 2018; 9():656. PubMed ID: 29670626
[TBL] [Abstract][Full Text] [Related]
17. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney.
Zhang JL; Sun DJ; Hou CM; Wei YL; Li XY; Yu ZY; Feng JN; Shen BF; Li Y; Xiao H
Transpl Immunol; 2010 Oct; 24(1):17-25. PubMed ID: 20850528
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease.
Kuroiwa T; Iwasaki T; Imado T; Sekiguchi M; Fujimoto J; Sano H
Arthritis Res Ther; 2006; 8(4):R123. PubMed ID: 16859527
[TBL] [Abstract][Full Text] [Related]
19. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
[TBL] [Abstract][Full Text] [Related]
20. TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells.
Gu J; Lu L; Chen M; Xu L; Lan Q; Li Q; Liu Z; Chen G; Wang P; Wang X; Brand D; Olsen N; Zheng SG
J Immunol; 2014 Oct; 193(7):3388-97. PubMed ID: 25156367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
